HIV-1 resistance in children aged 2 to <15 years receiving DTG/3TC or DTG+2NRTI: results from the D3/PENTA-21 trial over 96 weeks

26 Jul, 2026

Authors: Botha JC, Byott M, Chen W, Grant P, Spyer MJ, Wang R, Boles J, Gärtner K, Kamrunnahar K, Archary M, Violari A, Variava E, Cressey T, Ahimbisibwe G, Kekitiinwa A, Kityo C, Epalza C, Giaquinto C, Buchanan A, Ford D, Chan MK, Turkova A, Nastouli E, for the D3/PENTA21 trial team.

Presented at: International Workshop on Pediatrics and HIV